In addition, given that P301L and A152T differentially impact the biochemical and neuropathological profile of tau, this study has important implications for the utilization of pathogenic tau mutations that are not associated with AD to model Alzheimer’s tauopathy. The gene discussed is MAPT; the disease is Alzheimer disease.